Onno Bleijerveld

22PUBLICATIONS
139CO-AUTHORS
Molecular targetsTumour immunologyMedical molecular engineering of nucleic acids and proteinsGenome structure and regulationReaction engineering (excl. nuclear reactions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|May 07, 2026
Arginine Deprivation of ASS1-Deficient Cancers Drives Mistranslation and Shared Neoepitope Production.

|Jan 22, 2026
MHC1-TIP enables single-tube multimodal immunopeptidome profiling and uncovers intratumoral heterogeneity in antigen presentation.

Mayukha Bathini, Diana Bocaniciu, Fraser D Johnson

|Aug 13, 2025
NASP modulates histone turnover to drive PARP inhibitor resistance.

Sarah C Moser, Anna Khalizieva, Josef Roehsner

|Jul 11, 2025
TRIM33 loss reduces androgen receptor transcriptional output and H2BK120 ubiquitination.

Nils Eickhoff, Janina Janetzko, Nuno Padrão

|Jul 04, 2025
Cytidine diphosphate diacylglycerol synthase 2 is a synthetic lethal target in mesenchymal-like cancers.

Tim Arnoldus, Alex van Vliet, Onno B Bleijerveld

|Jun 24, 2025
The C-Terminal Kinase Domain-Binding and Suppression Motif Prevents Constitutive Activation of FGFR2.

Daniel Zingg, Chi-Chuan Lin, Julia Yemelyanenko

Pageof 4

Frequent Collaborators

9 joint publications

Liesbeth Hoekman

7 joint publications

Reuven Agami

6 joint publications

Julien Champagne

5 joint publications

Daniel S Peeper